Scholar Rock Holding Corp at JPMorgan Healthcare Conference TranscriptJan 09, 2024- Q3 2023 Scholar Rock Holding Corp Earnings Call TranscriptNov 07, 2023$12.35 (+1.48%)Earnings
- Scholar Rock Holding Corp Overview of the Current Treatment Landscape and Unmet Needs of Patients with SMA TranscriptJul 12, 2023
- Scholar Rock Holding Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Scholar Rock Holding Corp TOPAZ Phase 2 Clinical Trial Data TranscriptJun 17, 2022
- Scholar Rock Holding Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Scholar Rock Holding Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Scholar Rock Holding Corp to Host KOL Discussing Apitegromab's Therapeutic Potential in Patients with SMA Call TranscriptJun 15, 2021
- Scholar Rock Holding Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Scholar Rock Holding Corp Annual Shareholders Meeting TranscriptMay 27, 2021
- Scholar Rock Holding Corp to Announce the 12-Month Top-line Results of TOPAZ Phase 2 Trial TranscriptApr 06, 2021
- Scholar Rock Holding Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Scholar Rock Holding Corp to Discuss the SRK-015 TOPAZ Interim Analysis Results Conference Call TranscriptOct 27, 2020
- Scholar Rock Holding Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Scholar Rock Holding Corp Earnings Call TranscriptAug 07, 2020$14.07 (+2.25%)Earnings
- Scholar Rock Holding Corp Annual Shareholders Meeting TranscriptMay 29, 2020
- Scholar Rock Holding Corp at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Scholar Rock Holding Corp at Oppenheimer Healthcare Conference TranscriptMar 19, 2019
- Scholar Rock Holding Corp at Cowen Health Care Conference TranscriptMar 13, 2019
- Scholar Rock Holding Corp SRK-015 Interim Phase 1 Results and Phase 2 Trial Design Conference Call TranscriptFeb 26, 2019
Scholar Rock Holding Corp at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tessa Romero, I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team.
Our next presenting company is Scholar Rock. And presenting on behalf of the company, we have Jay Backstrom. And really, we're going to have a 20-minute formal presentation here, but we will follow it up with some Q&A. So there is a webcast with a Q&A portal, please submit your questions, or we're going to have a mic runner as well in the room to ask live audience questions as well.
With that, I'm going to hand it over to Jay.
All right. Well, thank you, Tessa. It's a pleasure to be here representing Scholar Rock at this year's JPMorgan Healthcare Conference. I'm pleased with our progress during the first 3 months as CEO, and I'm very excited about our future and for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
